Pharmacokinetic (PK) and pharmacodynamic analyses of once- and twice-daily darunavir/ritonavir (DRV/r) in the ODIN trial
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-2652
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Pharmacokinetic (PK) and pharmacodynamic analyses of once- and twice-daily darunavir/ritonavir (DRV/r) in the ODIN trial ; volume:13 ; number:4 ; day:8 ; month:11 ; year:2010 ; pages:1 ; date:12.2010
Journal of the International AIDS Society / International AIDS Society ; 13, Heft 4 (8.11.2010), 1, 12.2010
- Creator
-
Sekar, V.
- Contributor
-
De La Rosa, G.
Van de Casteele, T.
Spinosa-Guzman, S.
Vis, P.
Hoetelmans, RMW
SpringerLink (Online service)
- DOI
-
10.1186/1758-2652-13-S4-P185
- URN
-
urn:nbn:de:1111-2016052060430
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sekar, V.
- De La Rosa, G.
- Van de Casteele, T.
- Spinosa-Guzman, S.
- Vis, P.
- Hoetelmans, RMW
- SpringerLink (Online service)
Other Objects (12)
Health-related quality of life (HRQoL) assessment with once- and twice-daily darunavir/ritonavir (DRV/r) in the ODIN trial
Influence of demographic and disease parameters on virological response to once- vs twice-daily darunavir/ritonavir (DRV/r) at week 48 in ODIN
Population pharmacokinetic/pharmacodynamic analysis of lopinavir and ritonavir in subjects receiving the tablet formulation
twice"
"twice"
twicE | 200IX | tWiCe
"THINK TWICE"
twice PSB!
TWiCE
TWiCE
twice RSB!
TwicE
Health-related quality of life (HRQoL) assessment with once- and twice-daily darunavir/ritonavir (DRV/r) in the ODIN trial
Influence of demographic and disease parameters on virological response to once- vs twice-daily darunavir/ritonavir (DRV/r) at week 48 in ODIN
Population pharmacokinetic/pharmacodynamic analysis of lopinavir and ritonavir in subjects receiving the tablet formulation
twice"
"twice"
twicE | 200IX | tWiCe
"THINK TWICE"
twice PSB!
TWiCE
TWiCE
twice RSB!
TwicE
Health-related quality of life (HRQoL) assessment with once- and twice-daily darunavir/ritonavir (DRV/r) in the ODIN trial
Influence of demographic and disease parameters on virological response to once- vs twice-daily darunavir/ritonavir (DRV/r) at week 48 in ODIN
Population pharmacokinetic/pharmacodynamic analysis of lopinavir and ritonavir in subjects receiving the tablet formulation
twice"
"twice"
twicE | 200IX | tWiCe
"THINK TWICE"
twice PSB!
TWiCE
TWiCE
twice RSB!